Zimmer Biomet (ZBH)

NYSE Health Care Health Care Equipment S&P 500
$105.59
-1.26 (-1.18%)
Close of Nov 06, 2026 · end-of-day data
Source: Zimmer Biomet's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$7.67B$7.80B$7.93B$6.96B$6.13B$6.83B$6.94B$7.39B$7.68B$8.23B
Cost of revenue$2.38B$2.13B$2.27B$1.94B$1.82B$1.96B$2.02B$2.08B$2.19B$2.49B
Gross profit$5.29B$5.67B$5.66B$5.02B$4.30B$4.87B$4.92B$5.31B$5.49B$5.74B
Research & development$365.60M$369.90M$391.70M$394.10M$322.80M$435.80M$406.00M$458.70M$437.40M$458.50M
Selling, general & admin$2.94B$3.10B$3.38B$2.81B$2.71B$2.84B$2.76B$2.84B$2.93B$3.26B
Operating income$821.10M$799.30M$33.80M$1.11B$83.10M$860.30M$696.30M$1.28B$1.29B$1.10B
Interest expense$357.90M$327.50M————————
Pre-tax income$399.60M$464.60M-$271.10M$880.10M-$105.20M$499.00M$403.50M$1.07B$1.04B$830.80M
Income tax$95.00M-$1.35B$108.20M-$238.00M-$96.00M$53.50M$112.30M$42.20M$131.40M$125.70M
Net income$305.90M$1.81B-$379.20M$1.13B-$138.90M$401.60M$231.40M$1.02B$903.80M$705.10M
EBITDA$1.86B$1.86B$1.07B$1.98B$981.50M$1.80B$1.62B$2.23B$2.28B$2.19B
EPS (basic)$1.53$8.98$-1.86$5.52$-0.67$1.93$1.10$4.91$4.45$3.56
EPS (diluted)$1.51$8.90$-1.86$5.47$-0.67$1.91$1.10$4.88$4.43$3.55
Diluted shares202.40M203.70M203.50M206.70M207.00M210.40M210.30M209.70M203.90M198.70M
Gross margin68.9%72.7%71.4%72.1%70.2%71.3%70.9%71.8%71.5%69.7%
Operating margin10.7%10.2%0.4%16.0%1.4%12.6%10.0%17.3%16.7%13.3%
Net margin4.0%23.2%-4.8%16.3%-2.3%5.9%3.3%13.8%11.8%8.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$634.10M$524.40M$542.80M$617.90M$774.70M$378.10M$375.70M$415.80M$525.50M$591.90M
Receivables$1.60B$1.54B$1.28B$1.36B$1.28B$1.26B$1.38B$1.44B$1.48B$1.70B
Inventory$1.96B$2.07B$2.26B$2.38B$2.17B$2.15B$2.15B$2.39B$2.24B$2.29B
Total current assets$4.66B$4.56B$4.43B$4.72B$5.08B$4.88B$4.43B$4.61B$4.67B$5.12B
Goodwill$10.64B$10.67B$9.59B$9.20B$8.98B$8.92B$8.58B$8.82B$8.95B$9.95B
Total assets$26.68B$26.01B$24.13B$24.64B$24.42B$23.46B$21.07B$21.50B$21.37B$23.09B
Total current liabilities$2.38B$3.07B$2.42B$3.44B$2.56B$3.47B$2.36B$2.86B$2.45B$2.58B
Short-term debt$575.60M$1.23B$525.00M$1.50B$500.00M$1.61B$544.30M$900.00M$863.00M$587.10M
Long-term debt$10.67B$8.92B$8.41B$6.72B$7.63B$5.46B$5.15B$4.87B$5.34B$6.93B
Total debt$11.24B$10.14B$8.94B$8.22B$8.13B$7.07B$5.70B$5.77B$6.20B$7.52B
Total liabilities$17.01B$14.28B$12.85B$12.25B$12.22B$10.79B$9.04B$9.01B$8.89B$10.39B
Shareholders' equity$9.67B$11.74B$11.27B$12.39B$12.19B$12.66B$12.02B$12.48B$12.47B$12.70B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.63B$1.58B$1.75B$1.59B$1.20B$1.50B$1.36B$1.58B$1.50B$1.70B
Capital expenditures$184.70M$156.00M$162.70M$198.40M$111.90M$143.60M$187.90M$291.10M$203.80M$224.50M
Free cash flow$1.45B$1.43B$1.58B$1.39B$1.09B$1.36B$1.17B$1.29B$1.30B$1.47B
Investing cash flow-$1.69B-$510.80M-$416.60M-$729.30M-$613.80M-$503.60M-$522.00M-$778.90M-$888.10M-$1.98B
Financing cash flow-$743.20M-$1.21B-$1.30B-$779.90M-$421.80M-$1.31B-$775.70M-$763.50M-$484.50M$326.00M
Dividends paid$188.40M$193.60M$195.20M$196.70M$198.50M$200.10M$201.20M$200.90M$196.00M$190.30M
Share buybacks$415.50M—————$126.40M$692.20M$868.00M$487.00M
Stock-based compensation$57.30M$53.70M$65.50M$77.20M$73.80M$76.00M$105.00M$99.80M$101.00M$90.20M
Depreciation & amortization$1.04B$1.06B$1.04B$871.00M$898.40M$937.70M$926.40M$951.70M$996.30M$1.09B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.